Certified by Founder Lodge
EDBI Pte Ltd
Singapore - ND
INVESTOR
1 Disclosed Funding Rounds $14,000,000
34 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Investing since 1991, EDBI is a Singapore-based global investor in select high growth technology sectors ranging from Information & Communication Technology (ICT), Emerging Technology (ET), H
| Company | Date | Round | Raised |
|---|---|---|---|
Neuron Mobility |
April, 27 ,2022 | Series B | $43,500,000 |
Funding Societies | Modalku Group |
February, 16 ,2022 | Series C | $144,000,000 |
Engine Biosciences |
November, 01 ,2023 | Series A | $27,000,000 |
ImmunoScape |
September, 26 ,2022 | Unknown | $14,000,000 |
Biofourmis |
April, 26 ,2022 | Series D | $300,000,000 |
FAZZ Financial Group |
September, 14 ,2022 | Series C | $100,000,000 |
Next Gen Foods | Makers of TiNDLE |
February, 15 ,2022 | Series A | $100,000,000 |
Callio Therapeutics |
March, 06 ,2025 | Series A | $187,000,000 |
Aspen Neuroscience, Inc. |
May, 09 ,2022 | Series B | $147,500,000 |
Beam Mobility |
February, 25 ,2022 | Series B | $93,000,000 |
Endowus |
August, 09 ,2023 | Unknown | $35,000,000 |
VFlowTech |
May, 15 ,2025 | Unknown | $20,500,000 |
Neuron Mobility |
April, 27 ,2022 | Series B | $43,500,000 |
Funding Societies | Modalku Group |
February, 16 ,2022 | Series C | $144,000,000 |
Engine Biosciences |
November, 01 ,2023 | Series A | $27,000,000 |
Next Gen Foods | Makers of TiNDLE |
February, 15 ,2022 | Series A | $100,000,000 |
Biofourmis |
April, 26 ,2022 | Series D | $300,000,000 |
Endowus |
August, 09 ,2023 | Unknown | $35,000,000 |
Callio Therapeutics |
March, 06 ,2025 | Series A | $187,000,000 |
Engine Biosciences |
November, 01 ,2023 | Series A | $27,000,000 |
Beam Mobility |
February, 25 ,2022 | Series B | $93,000,000 |
Callio Therapeutics |
March, 06 ,2025 | Series A | $187,000,000 |
VFlowTech |
May, 15 ,2025 | Unknown | $20,500,000 |
VFlowTech |
May, 15 ,2025 | Unknown | $20,500,000 |
Funding Societies | Modalku Group |
February, 16 ,2022 | Series C | $144,000,000 |
Next Gen Foods | Makers of TiNDLE |
February, 15 ,2022 | Series A | $100,000,000 |
Tacta Systems, Inc. |
June, 27 ,2025 | Unknown | $7,000,000 |
Endowus |
August, 09 ,2023 | Unknown | $35,000,000 |
Augmentus Robotics |
July, 11 ,2025 | Series A | $11,000,000 |
Engine Biosciences |
November, 01 ,2023 | Series A | $27,000,000 |
Callio Therapeutics |
March, 06 ,2025 | Series A | $187,000,000 |
VFlowTech |
May, 15 ,2025 | Unknown | $20,500,000 |
Tacta Systems, Inc. |
June, 27 ,2025 | Unknown | $7,000,000 |
Augmentus Robotics |
July, 11 ,2025 | Series A | $11,000,000 |
Neuron Mobility
Funding Societies | Modalku Group
Engine Biosciences
ImmunoScape
Biofourmis
FAZZ Financial Group
Next Gen Foods | Makers of TiNDLE
Callio Therapeutics
Aspen Neuroscience, Inc.
Beam Mobility
Endowus
VFlowTech
Tacta Systems, Inc.
Augmentus Robotics
Founderpath
Truework
Finix
Farther
TeamApt Inc.
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)